[1]
|
Rodriguez-Fernandez, R., Mejias, A. and Ramilo, O. (2021) Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Infection. Pediatric Infectious Disease Journal, 40, S35-S39. https://doi.org/10.1097/inf.0000000000003121
|
[2]
|
Ouyang, Y., Liao, H., Hu, Y., Luo, K., Hu, S. and Zhu, H. (2022) Innate Immune Evasion by Human Respiratory Syncytial Virus. Frontiers in Microbiology, 13, Article 865592. https://doi.org/10.3389/fmicb.2022.865592
|
[3]
|
Kopera, E., Czajka, H., Zapolnik, P. and Mazur, A. (2023) New Insights on Respiratory Syncytial Virus Prevention. Vaccines, 11, Article 1797. https://doi.org/10.3390/vaccines11121797
|
[4]
|
Dransfield, M.T., Kunisaki, K.M., Strand, M.J., Anzueto, A., Bhatt, S.P., Bowler, R.P., et al. (2017) Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 195, 324-330. https://doi.org/10.1164/rccm.201605-1014oc
|
[5]
|
Liu, D., Tang, Z., Bajinka, O., Dai, P., Wu, G., Qin, L., et al. (2023) miR-34b/c-5p/CXCL10 Axis Induced by RSV Infection Mediates a Mechanism of Airway Hyperresponsive Diseases. Biology, 12, Article 317. https://doi.org/10.3390/biology12020317
|
[6]
|
Wilkinson, T.M.A., Donaldson, G.C., Johnston, S.L., Openshaw, P.J.M. and Wedzicha, J.A. (2006) Respiratory Syncytial Virus, Airway Inflammation, and Fev1 Decline in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 173, 871-876. https://doi.org/10.1164/rccm.200509-1489oc
|
[7]
|
Sikkel, M.B., Quint, J.K., Mallia, P., Wedzicha, J.A. and Johnston, S.L. (2008) Respiratory Syncytial Virus Persistence in Chronic Obstructive Pulmonary Disease. Pediatric Infectious Disease Journal, 27, S63-S70. https://doi.org/10.1097/inf.0b013e3181684d67
|
[8]
|
Carty, M., Guy, C. and Bowie, A.G. (2021) Detection of Viral Infections by Innate Immunity. Biochemical Pharmacology, 183, Article ID: 114316. https://doi.org/10.1016/j.bcp.2020.114316
|
[9]
|
Sedeyn, K., Schepens, B. and Saelens, X. (2019) Respiratory Syncytial Virus Nonstructural Proteins 1 and 2: Exceptional Disrupters of Innate Immune Responses. PLOS Pathogens, 15, e1007984. https://doi.org/10.1371/journal.ppat.1007984
|
[10]
|
Fitzgerald, K.A. and Kagan, J.C. (2020) Toll-like Receptors and the Control of Immunity. Cell, 180, 1044-1066. https://doi.org/10.1016/j.cell.2020.02.041
|
[11]
|
Gao, W., Li, L., Wang, Y., Zhang, S., Adcock, I.M., Barnes, P.J., et al. (2015) Bronchial Epithelial Cells: The Key Effector Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease? Respirology, 20, 722-729. https://doi.org/10.1111/resp.12542
|
[12]
|
Chen, Y., Lin, J., Zhao, Y., Ma, X. and Yi, H. (2021) Toll-like Receptor 3 (TLR3) Regulation Mechanisms and Roles in Antiviral Innate Immune Responses. Journal of Zhejiang University-SCIENCE B, 22, 609-632. https://doi.org/10.1631/jzus.b2000808
|
[13]
|
Liu, D., Chen, Q., Zhu, H., Gong, L., Huang, Y., Li, S., et al. (2017) Association of Respiratory Syncytial Virus Toll-Like Receptor 3-Mediated Immune Response with COPD Exacerbation Frequency. Inflammation, 41, 654-666. https://doi.org/10.1007/s10753-017-0720-4
|
[14]
|
Alshaghdali, K., Saeed, M., Kamal, M.A. and Saeed, A. (2021) Interaction of Ectodomain of Respiratory Syncytial Virus G Protein with TLR2/TLR6 Heterodimer: An in Vitro and in Silico Approach to Decipher the Role of RSV G Protein in Pro-Inflammatory Response against the Virus. Current Pharmaceutical Design, 27, 4464-4476. https://doi.org/10.2174/1381612827666210716160030
|
[15]
|
Lukacs, N.W., Smit, J.J., Mukherjee, S., Morris, S.B., Nunez, G. and Lindell, D.M. (2010) Respiratory Virus-Induced TLR7 Activation Controls Il-17–associated Increased Mucus via IL-23 Regulation. The Journal of Immunology, 185, 2231-2239. https://doi.org/10.4049/jimmunol.1000733
|
[16]
|
Miles, M.A., Liong, S., Liong, F., Coward-Smith, M., Trollope, G.S., Oseghale, O., et al. (2023) TLR7 Promotes Chronic Airway Disease in RSV-Infected Mice. Frontiers in Immunology, 14, Article 1240552. https://doi.org/10.3389/fimmu.2023.1240552
|
[17]
|
Seth, R.B., Sun, L., Ea, C. and Chen, Z.J. (2005) Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein That Activates NF-κB and IRF 3. Cell, 122, 669-682. https://doi.org/10.1016/j.cell.2005.08.012
|
[18]
|
Rehwinkel, J. and Gack, M.U. (2020) RIG-I-like Receptors: Their Regulation and Roles in RNA Sensing. Nature Reviews Immunology, 20, 537-551. https://doi.org/10.1038/s41577-020-0288-3
|
[19]
|
Pei, J., Wagner, N.D., Zou, A.J., Chatterjee, S., Borek, D., Cole, A.R., et al. (2021) Structural Basis for IFN Antagonism by Human Respiratory Syncytial Virus Nonstructural Protein 2. Proceedings of the National Academy of Sciences of the United States of America, 118, e2020587118. https://doi.org/10.1073/pnas.2020587118
|
[20]
|
Schwab, L.S.U., Farrukee, R., Eléouët, J., Rameix-Welti, M., Londrigan, S.L., Brooks, A.G., et al. (2022) Retinoic Acid-Inducible Gene I Activation Inhibits Human Respiratory Syncytial Virus Replication in Mammalian Cells and in Mouse and Ferret Models of Infection. The Journal of Infectious Diseases, 226, 2079-2088. https://doi.org/10.1093/infdis/jiac295
|
[21]
|
Demoor, T., Petersen, B.C., Morris, S., Mukherjee, S., Ptaschinski, C., De Almeida Nagata, D.E., et al. (2012) IPS-1 Signaling Has a Nonredundant Role in Mediating Antiviral Responses and the Clearance of Respiratory Syncytial Virus. The Journal of Immunology, 189, 5942-5953. https://doi.org/10.4049/jimmunol.1201763
|
[22]
|
Sabbah, A., Chang, T.H., Harnack, R., Frohlich, V., Tominaga, K., Dube, P.H., et al. (2010) Erratum: Corrigendum: Activation of Innate Immune Antiviral Responses by Nod2. Nature Immunology, 11, 969-969. https://doi.org/10.1038/ni1010-969b
|
[23]
|
Segovia, J., Sabbah, A., Mgbemena, V., Tsai, S., Chang, T., Berton, M.T., et al. (2012) TLR2/MyD88/NF-κB Pathway, Reactive Oxygen Species, Potassium Efflux Activates NLRP3/ASC Inflammasome during Respiratory Syncytial Virus Infection. PLOS ONE, 7, e29695. https://doi.org/10.1371/journal.pone.0029695
|
[24]
|
Sun, Y. and López, C.B. (2017) The Innate Immune Response to RSV: Advances in Our Understanding of Critical Viral and Host Factors. Vaccine, 35, 481-488. https://doi.org/10.1016/j.vaccine.2016.09.030
|
[25]
|
Varricchi, G., Harker, J., Borriello, F., Marone, G., Durham, S.R. and Shamji, M.H. (2016) T Follicular Helper (tfh) Cells in Normal Immune Responses and in Allergic Disorders. Allergy, 71, 1086-1094. https://doi.org/10.1111/all.12878
|
[26]
|
Blanken, M.O., Rovers, M.M., Molenaar, J.M., Winkler-Seinstra, P.L., Meijer, A., Kimpen, J.L.L., et al. (2013) Respiratory Syncytial Virus and Recurrent Wheeze in Healthy Preterm Infants. New England Journal of Medicine, 368, 1791-1799. https://doi.org/10.1056/nejmoa1211917
|
[27]
|
Spann, K.M., Tran, K., Chi, B., Rabin, R.L. and Collins, P.L. (2004) Suppression of the Induction of Alpha, Beta, and Gamma Interferons by the NS1 and NS2 Proteins of Human Respiratory Syncytial Virus in Human Epithelial Cells and Macrophages. Journal of Virology, 78, 4363-4369. https://doi.org/10.1128/jvi.78.8.4363-4369.2004
|
[28]
|
Thornhill, E.M. and Verhoeven, D. (2020) Respiratory Syncytial Virus’s Non-Structural Proteins: Masters of Interference. Frontiers in Cellular and Infection Microbiology, 10, Article 225. https://doi.org/10.3389/fcimb.2020.00225
|
[29]
|
祖向阳, 高伟娜, 杜喆, 等. 呼吸道合胞病毒疫苗的研究进展[J]. 中国疫苗和免疫, 2018, 24(2): 237-242.
|
[30]
|
Cunningham, C.K., Karron, R.A., Muresan, P., Kelly, M.S., McFarland, E.J., Perlowski, C., et al. (2022) Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/δNS2/δ1313/I1314L and RSV/276 in RSV-Seronegative Children. The Journal of Infectious Diseases, 226, 2069-2078. https://doi.org/10.1093/infdis/jiac253
|
[31]
|
Stuart, A.S.V., Virta, M., Williams, K., Seppa, I., Hartvickson, R., Greenland, M., et al. (2022) Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18-50 Years and RSV-Seropositive Children 12-24 Months. The Journal of Infectious Diseases, 227, 71-82. https://doi.org/10.1093/infdis/jiac407
|
[32]
|
Regev-Yochay, G., Gonen, T., Gilboa, M., Mandelboim, M., Indenbaum, V., Amit, S., et al. (2022) Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron. New England Journal of Medicine, 386, 1377-1380. https://doi.org/10.1056/nejmc2202542
|
[33]
|
Walsh, E.E., Pérez Marc, G., Zareba, A.M., Falsey, A.R., Jiang, Q., Patton, M., et al. (2023) Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults. New England Journal of Medicine, 388, 1465-1477. https://doi.org/10.1056/nejmoa2213836
|